Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Remyelination of the Corpus Callosum by Olfactory Ensheathing Cell in an Experimental Model of Multiple Sclerosis.
Detection of olfactory dysfunction using olfactory event related potentials in young patients with multiple sclerosis.
Recurrent paraparesis and death of a patient with 'whippet' abuse.
Corrigendum to "Cardiovascular autonomic dysfunction in multiple sclerosis: A meta-analysis" [Mult. Scler. Relat. Disord. 4 (2015) 104-111].
Effect of light finger touch in balance control of individuals with multiple sclerosis.
Corticospinal tract integrity measured using transcranial magnetic stimulation and magnetic resonance imaging in neuromyelitis optica and multiple sclerosis.
T1- Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients.
Re. 'Doppler Ultrasound Examination of Multiple Sclerosis Patients and Control Participants: Inter-observer Agreement and Association with Disease'
Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra.
Serum 25(OH) Vitamin D levels is not associated with disability in multiple sclerosis patients: A case-control study.
Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation via Fumaric Acid Esters.
The current role of mitoxantrone in the treatment of multiple sclerosis.
Laquinimod in the treatment of multiple sclerosis: a review of the data so far.
Assessment of a program to encourage the multidisciplinary management of urinary disorders in multiple sclerosis.
Outcomes after Microvascular Decompression for Patients with Trigeminal Neuralgia and Suspected Multiple Sclerosis.
Hippocampal Neuroinflammation, Functional Connectivity, and Depressive Symptoms in Multiple Sclerosis.
An updated role of microRNA-124 in central nervous system disorders: a review.
Recessively transmitted predominantly motor neuropathies.
[Oral treatments in multiple sclerosis].
Pharmacodynamics and tolerability of repository corticotropin injection in healthy human subjects: A comparison with intravenous methylprednisolone.
An Optimized Immunohistochemistry Technique Improves NMO-IgG Detection: Study Comparison with Cell-Based Assays.
Comparison of Vitamin D3 Serum Levels in New Diagnosed Patients with Multiple Sclerosis versus Their Healthy Relatives.
Noradrenergic regulation of glial activation: molecular mechanisms and therapeutic implications.
Preliminary validation of the short physical performance battery in older adults with multiple sclerosis: secondary data analysis.
Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy.
Pages
« first
‹ previous
…
534
535
536
537
538
539
540
541
542
…
next ›
last »